- Home
- Clinical Trials
Sarbecovirus Vaccine Studies Sydney DH
Sarbecovirus Vaccine Study
Darlinghurst Sydney
Are you a healthy adult interested in contributing to important vaccine research?
Momentum Clinical Research is conducting a clinical research study evaluating an investigational coronavirus vaccine designed to provide broader protection against current and future coronavirus strains.
By taking part in this study, you may help researchers better understand new vaccine technologies that aim to improve preparedness for future coronavirus outbreaks. Participants will receive health checks, close medical monitoring and support from a professional medical team throughout the duration of the study.
Description
What to expect
Study details
Ages
18 to 55 years of age
Duration
The study duration is up to 14 months, including up to 11 in clinic visits
Compensation
Participants will be compensated up to $1,900
Eligibility Criteria
You may be eligible if you:
- Are aged 18 to 55 years
- Are generally healthy
- Have previously received COVID-19 vaccinations including at least one booster
- Have received a COVID-19 vaccine at least 6 months go
- Have not had COVID-19 in the past 6 months
Other eligibility criteria apply.
Locations
Description
Coronaviruses, including those that cause COVID-19, continue to evolve and pose an ongoing global health challenge. While existing vaccines have been highly effective at reducing severe illness and hospitalisation, new variants and related coronaviruses can change over time, which may affect how long protection lasts.
Vaccines work by training the immune system to recognise and respond to viruses before illness occurs. This clinical research study is evaluating an investigational vaccine designed to stimulate a broader immune response, with the aim of helping the body recognise shared features across a range of coronaviruses. By targeting these common features, this approach may support protection not only against current viruses, but also against related coronaviruses that could emerge in the future.
This study is exploring a new vaccine strategy that looks beyond individual variants and focuses on longer-term preparedness. The study will help researchers better understand how the immune system responds to this investigational vaccine and how it may contribute to future vaccine development.
This is an early-phase clinical research study. Participants are not expected to receive a direct health benefit. However, the information collected may help researchers develop future vaccines that could improve global pandemic preparedness.
What to expect
Participants will be randomly assigned to receive either the investigational vaccine or a control vaccine (already approved vaccine). Depending on the study group, you may receive one or two injections during scheduled clinic visits.
Throughout the study you will attend regular clinic visits for health assessments, which may include physical examinations, blood tests, and general health checks. These visits help the research team monitor your health and collect important study information.
Your safety and wellbeing will be closely monitored by our professional clinical team for the duration of the study
Why join this clinical research study?
- Contribute to important medical research that supports future vaccine development
- Receive study-related health checks at no cost
- Be support and monitored by a professional clinical research team
- Be compensated for your time and travel
Your privacy is important and all personal information will be kept strictly confidential.
Register your interest today.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research AU is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. Our Privacy Policy also contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.